Our Take
India's private hospital pricing opacity is structural, not inevitable—hospitals know their costs but profit from variability.
Why it matters
India faces a three-million-bed shortage while patients absorb unpredictable bills out of medical necessity. A CEO arguing the problem is solvable system design, not medical complexity, matters because it reframes where pressure should land: on hospital economics, not clinical complexity.
Do this week
Hospital operators: audit your procedure-cost variance across identical cases and surgeon experience levels over the next 30 days, then publish bundled pricing for your top 20 procedures so you can eliminate the opaqueness that currently lets margin variability hide as clinical unpredictability.
The pricing problem is structural, not clinical
Varun Dubey, CEO of Superhealth, argues that India's private hospital sector conflates two separate things: medical outcome unpredictability and billing unpredictability. The first is real. The second is not.
Hospital bills for identical procedures vary widely, but Dubey rejects the premise that this is inevitable. He claims only about five percent of cases genuinely vary in cost, not fifty percent. When a surgeon performs a procedure ten times daily for twenty years, the cost structure should be knowable.
The real driver is how hospital economics are built. Operating theatre charges are often pegged to surgeon fees—a surgeon with five years of experience commanding Rs 50,000 generates identical OT charges, while a surgeon with 25 years of experience at Rs 1.5 lakh triggers proportionally higher OT costs, even though greater experience often means faster surgery. This is pricing structure, not clinical necessity.
Dubey also cites India's three-million-bed shortage (the country needs four million beds but operates roughly one million). Constrained supply means patients proceed with treatment regardless of price clarity. Billing opacity persists because the system structurally benefits from it.
India's healthcare structure is not the West's
India operates a consumer and provider-driven system, not a payer-driven one like the US or a government-rationed one like the UK. This matters because the structural fixes differ.
India's median age is 28; the West's is in the late 40s or 50s. Disease profiles are different. Yet hospital infrastructure has been copied wholesale from Western models designed for low-density cities and long travel times. Indian cities are dense; patients want care nearby. The supply gap means demand always exceeds capacity.
Urbanization, lifestyle diseases, and rising patient expectations are accelerating demand. Against that backdrop, pricing opacity is not a friction cost—it is a feature. Hospitals with full waiting lists have no incentive to reveal true costs when patients cannot decline treatment.
Redesign scheduling and cost certainty together
Superhealth's approach is to treat waiting time and billing transparency as linked operational problems, not separate complaints. The company is experimenting with a "zero wait time" model that attempts to streamline scheduling and workflows so patients know when they will be seen, how long treatment will take, and what it will cost.
Dubey's argument is that operational efficiency and cost transparency reinforce each other. If a hospital can eliminate much of the waiting that exists for organizational reasons rather than clinical reasons, it can also predictably cost procedures and compete on both speed and price. Traditional hospital models have not managed this tradeoff.
The structural insight is simple: costs are predictable when systems are designed to be predictable. Waiting and billing opacity are not medical byproducts; they are business model choices.